drugset / Trial / NCT00302640

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

NCT00302640

Phase 2/3 Completed 50 enrolled Romark Laboratories L.C.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by enteric viruses in children less than 12 years of age.

Timeline

Start
2005-02
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitazoxanide Other / unclassified 7.5 mg/kg Oral
Comparator Nitazoxanide Other / unclassified 100 mg Oral
Comparator Nitazoxanide Other / unclassified 200 mg Oral